[Indications]  

For the prevention of pneumococcal infections, in particular pneumonia, caused by the serotypes contained in the vaccine, for subjects at risk, from the age of 2 years. 

[Specification] 

0.5ml /vial /dose

25 µg for each of the 23 serotypes/ for one 0.5 ml dose

[Dosage Form]

Liquid for Injection

[Route of Administration] 

intramuscular (IM) or subcutaneous (SC) injection

[Shelf life] 

24 months